GTS Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,000
Closed -$76.3K 2327
2024
Q3
$76.3K Sell
11,000
-1,200
-10% -$9.42K ﹤0.01% 3838
2024
Q2
$95.2K Sell
12,200
-12,500
-51% -$92.6K ﹤0.01% 3628
2024
Q1
$175K Sell
24,700
-14,100
-36% -$93.3K ﹤0.01% 3384
2023
Q4
$260K Sell
38,800
-3,300
-8% -$18.6K ﹤0.01% 3337
2023
Q3
$237K Buy
+42,100
New +$281K ﹤0.01% 3272

Other funds holding GDRX

GTS Securities's GDRX Position: Q1 2024 in Review

GTS Securities sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 18,204 shares — an estimated $120K sold.

GTS Securities first reported a position in GDRX in Q2 2023 and held it in 3 quarters. The position peaked at $162K in Q2 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • GTS Securities reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 18,204 GoodRx Holdings shares in Q1 2024, an estimated $120K.
  • GTS Securities first reported a position in GoodRx Holdings in Q2 2023 and held it in 3 quarters.
  • GTS Securities's GoodRx Holdings position peaked at $162K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.